Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphomaGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 9, pp 1047-1062, issn 0269-2813, 16 p.Article

Review article: rifabutin in the treatment of refractory Helicobacter pylori infectionGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2012, Vol 35, Num 2, pp 209-221, issn 0269-2813, 13 p.Article

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pyloriGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 6, pp 604-617, issn 0269-2813, 14 p.Article

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enoughGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 11-12, pp 1255-1268, issn 0269-2813, 14 p.Article

Review article: Helicobacterpylori-negative duodenal ulcer diseaseGISBERT, J. P; CALVET, X.Alimentary pharmacology & therapeutics. 2009, Vol 30, Num 8, pp 791-815, issn 0269-2813, 25 p.Article

Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers: a cost-effectiveness analysisGENE, E; CALVET, X; AZAGRA, R et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 4, pp 433-442, issn 0269-2813Article

Profilaxis de la hemorragia secundaria a lesiones agudas de la mucosa gástrica = Prophylaxis of hemorrhage secondary to acute lesions of the gastric mucosaBONSOMS, N; ARTIGAS, A; VALLES, J et al.Medicina intensiva (Madrid. Ed. impresa). 1992, Vol 16, Num 9, pp 499-509, issn 0210-5691Article

Portal pressure in patients with exudative ascites in the course of acute hepatitis BCALVET, X; BRUIX, J; BOSCH, J et al.Liver (Copenhagen). 1991, Vol 11, Num 4, pp 206-210, issn 0106-9543, 5 p.Article

Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysisGENE, E; CALVET, X; AZAGRA, R et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 9, pp 1137-1143, issn 0269-2813, 7 p.Article

What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysisCALVET, X; GENE, E; LOPEZ, T et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 7, pp 1067-1076, issn 0269-2813Article

Comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradicationVERGARA, M; VALLVE, M; GISBERT, J. P et al.Alimentary pharmacology & therapeutics. 2003, Vol 18, Num 6, pp 647-654, issn 0269-2813, 8 p.Article

Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysisVALLVE, M; VERGARA, . M; GISBERT, J. P et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 6, pp 1149-1156, issn 0269-2813Article

Meta-analysis : role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID usersVERGARA, M; CATALAN, M; GISBERT, J. P et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 12, pp 1411-1418, issn 0269-2813, 8 p.Article

Systematic review: rabeprazole-based therapies in Helicobacter pylori eradicationGISBERT, J. P; KHORRAMI, S; CALVET, X et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 6, pp 751-764, issn 0269-2813, 14 p.Article

Prevalence of Helicobacter pylori infection in the Vallès Occidental, CataloniaNAVARRO, M; CALVET, X; FONT, B et al.Clinical microbiology and infection. 1999, Vol 5, Num 11, pp 704-706, issn 1198-743XArticle

Radiological diagnosis of inorganic lead poisoningROVIRA, M; CALVET, X; ROS, E et al.Journal of clinical gastroenterology. 1989, Vol 11, Num 4, pp 469-470, issn 0192-0790Article

High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication ratesSANCHEZ-DELGADO, J; GARCIA-IGLESIAS, P; CALVET, X et al.Alimentary pharmacology & therapeutics. 2012, Vol 36, Num 2, pp 190-196, issn 0269-2813, 7 p.Article

Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcerGÜELL, M; ARTIGAU, E; ESTEVE, V et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 1, pp 53-59, issn 0269-2813, 7 p.Article

7-day rescue therapy with ranitidine bismuth citrate after helicobacter pylori treatment failureGISBERT, J. P; FUENTES, J; CARPIO, D et al.Alimentary pharmacology & therapeutics. 2005, Vol 21, Num 10, pp 1249-1253, issn 0269-2813, 5 p.Article

Meta-analysis: Helicobacter pylori eradication therapy vs antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcerGISBERT, J. P; KHORRAMI, S; CARBALLO, F et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 6, pp 617-629, issn 0269-2813, 13 p.Article

Pancreatic pseudocyst secondary to chemotherapy for acute lymphoblastic leukaemia : successful percutaneous drainageSIERRA, J; MARTI, J. M; BATALLER, R et al.(The) European journal of medicine. 1992, Vol 1, Num 6, pp 370-371Article

Proton pump inhibitors versus H₂-antagonists : a meta-analysis of their efficacy in treating bleeding peptic ulcerGISBERT, J. P; GONZALEZ, L; CALVET, X et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 7, pp 917-926, issn 0269-2813Article

Effect of sucralfate on gastric intramucosal pH in critically ill patientsCALVET, X; BAIGORRI, F; DUARTE, M et al.Intensive care medicine (Print). 1997, Vol 23, Num 7, pp 738-742, issn 0342-4642Article

Phase II study of transarterial embolization in European patients with hepatocellular carcinoma : need for controlled trialsBRUIX, J; CASTELLS, A; RODES, J et al.Hepatology (Baltimore, Md.). 1994, Vol 20, Num 3, pp 643-650, issn 0270-9139Article

Prognostic factors of hepatocellular carcinoma in the West : a multivariate analysis in 206 patientsCALVET, X; BRUIX, J; GINES, P et al.Hepatology (Baltimore, Md.). 1990, Vol 12, Num 4, pp 753-760, issn 0270-9139, 8 p., 1Article